Related Experiment Video
Updated: May 6, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Novel antiviral agents for respiratory viral infection in immunocompromised adults
Dana Hawkinson1, Daniel Hinthorn, Lara Danziger-Isakov
1Department of Medicine, Division of Infectious Diseases, University of Kansas Medical Center, Kansas City, KS, USA, DHAWKINSON@kumc.edu.
Abstract:
Respiratory viruses cause significant morbidity and mortality in immunocompromised populations such as stem cell transplant and solid organ transplant patients. Few viruses causing respiratory tract infection have an approved therapy, and many of the viruses have no therapeutic options at all. In this article, we describe novel agents under development for treatment options against several respiratory viruses.
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Subviral Agents
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Inhibitors of Viral Protein Synthesis

